These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17130787)

  • 21. Brief report--human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes.
    Yen BL; Chang CJ; Liu KJ; Chen YC; Hu HI; Bai CH; Yen ML
    Stem Cells; 2009 Feb; 27(2):451-6. PubMed ID: 18988708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human mesenchymal stem cells promote survival of T cells in a quiescent state.
    Benvenuto F; Ferrari S; Gerdoni E; Gualandi F; Frassoni F; Pistoia V; Mancardi G; Uccelli A
    Stem Cells; 2007 Jul; 25(7):1753-60. PubMed ID: 17395776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model.
    Wan CD; Cheng R; Wang HB; Liu T
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):29-33. PubMed ID: 18234635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoregulatory function of mesenchymal stem cells.
    Uccelli A; Moretta L; Pistoia V
    Eur J Immunol; 2006 Oct; 36(10):2566-73. PubMed ID: 17013987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes.
    Le Blanc K; Rasmusson I; Götherström C; Seidel C; Sundberg B; Sundin M; Rosendahl K; Tammik C; Ringdén O
    Scand J Immunol; 2004 Sep; 60(3):307-15. PubMed ID: 15320889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity.
    Li N; Feugier P; Serrurrier B; Latger-Cannard V; Lesesve JF; Stoltz JF; Eljaafari A
    Exp Hematol; 2007 Mar; 35(3):507-15. PubMed ID: 17309831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
    Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
    Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
    Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
    Müller I; Kordowich S; Holzwarth C; Isensee G; Lang P; Neunhoeffer F; Dominici M; Greil J; Handgretinger R
    Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
    Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
    Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.
    Bacigalupo A; Valle M; Podestà M; Pitto A; Zocchi E; De Flora A; Pozzi S; Luchetti S; Frassoni F; Van Lint MT; Piaggio G
    Exp Hematol; 2005 Jul; 33(7):819-27. PubMed ID: 15963858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium.
    von Bonin M; Stölzel F; Goedecke A; Richter K; Wuschek N; Hölig K; Platzbecker U; Illmer T; Schaich M; Schetelig J; Kiani A; Ordemann R; Ehninger G; Schmitz M; Bornhäuser M
    Bone Marrow Transplant; 2009 Feb; 43(3):245-51. PubMed ID: 18820709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum.
    Le Blanc K; Samuelsson H; Lönnies L; Sundin M; Ringdén O
    Transplantation; 2007 Oct; 84(8):1055-9. PubMed ID: 17989613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura.
    Pérez-Simón JA; Tabera S; Sarasquete ME; Díez-Campelo M; Canchado J; Sánchez-Abarca LI; Blanco B; Alberca I; Herrero-Sánchez C; Cañizo C; San Miguel JF
    Cytotherapy; 2009; 11(6):698-705. PubMed ID: 19878056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.
    Bernardo ME; Avanzini MA; Perotti C; Cometa AM; Moretta A; Lenta E; Del Fante C; Novara F; de Silvestri A; Amendola G; Zuffardi O; Maccario R; Locatelli F
    J Cell Physiol; 2007 Apr; 211(1):121-30. PubMed ID: 17187344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
    Aksu AE; Horibe E; Sacks J; Ikeguchi R; Breitinger J; Scozio M; Unadkat J; Feili-Hariri M
    Clin Immunol; 2008 Jun; 127(3):348-58. PubMed ID: 18387852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in vitro assay to evaluate the immunomodulatory effects of unrestricted somatic stem cells.
    Ebrahimi H; Soleimani M; Kazemi Arababadi M; Ahmadbeigi N; Hassanshahi G; Farjadfar A; Kennedy D
    Iran J Immunol; 2010 Mar; 7(1):30-8. PubMed ID: 20371917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of various irradiation doses on the growth and differentiation of marrow-derived human mesenchymal stromal cells.
    Li J; Kwong DL; Chan GC
    Pediatr Transplant; 2007 Jun; 11(4):379-87. PubMed ID: 17493217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.